{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:21:18Z","timestamp":1788355278936,"version":"build-2803163510"},"reference-count":45,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"unspecified","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["N\/A."],"award-info":[{"award-number":["N\/A."]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2026,5,22]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) frequently coexist in the same individual. Dyslipidemia plays a central role in the pathogenesis of MASLD. Remnant cholesterol (RC) is the cholesterol content carried in triglyceride-rich lipoproteins. We aimed to examine the association of RC, its discordance with low-density lipoprotein cholesterol (LDL-C) in terms of MASLD risk in patients with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>A total of 26\u2009302\u2009T2DM patients who were hospitalized were cross-sectionally assessed. Logistic regression models were employed to assess the associations. We used three approaches to assess the effects of the discordance between RC and LDL-C on MASLD risk: clinical cut-off points, differences of &gt;10 percentile points and residuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age was 62.0 years, and 48.3% had MASLD. RC was more closely associated with MASLD than LDL-C. Furthermore, discordantly high RC was associated with higher MASLD risk than discordantly high LDL-C, regardless of which method of discordance analysis is used. For example, for the residual approach, in a regression model including LDL-C and RC residual, the latter, representing the portion of RC not explained by LDL-C, was more associated with MASLD risk than LDL-C (OR=1.26, 95%\u2009CI 1.22 to 1.30 for RC residual and OR=1.04, 95%\u2009CI 1.01 to 1.07 for LDL-C); in a regression model including RC and LDL-C residual, the latter representing the portion of LDL-C not explained by RC, RC was more associated with MASLD risk than LDL-C residual (OR=1.24, 95%\u2009CI 1.20 to 1.29 for RC and OR=1.09, 95%\u2009CI 1.06 to 1.12 for LDL-C residual).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Discordantly high RC was associated with higher MASLD risk than discordantly high LDL-C. Our findings suggest that RC may serve as a potential target for prevention and intervention for MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2025-005841","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:15:12Z","timestamp":1781612112000},"page":"e005841","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Discordant high remnant cholesterol with LDL-C increases the metabolic dysfunction-associated steatotic liver disease risk in patients with type 2 diabetes mellitus"],"prefix":"10.1136","volume":"14","author":[{"given":"Ying","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"Hubei Provincial Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"Hubei Provincial Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"Hubei Provincial Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8146-8040","authenticated-orcid":false,"given":"Yan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"Hubei Provincial Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9645-2789","authenticated-orcid":false,"given":"Tingting","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China"},{"name":"Hubei Provincial Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Wuhan, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2026090206000748000_14.3.e005841.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.05.013"},{"key":"2026090206000748000_14.3.e005841.2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0431"},{"key":"2026090206000748000_14.3.e005841.3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1556\/650.2022.32480","article-title":"Non-alcoholic fatty liver disease and type 2 diabetes mellitus. II. Treatment","volume":"163","author":"P\u00e1r","year":"2022","journal-title":"Orv Hetil"},{"key":"2026090206000748000_14.3.e005841.4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330110"},{"key":"2026090206000748000_14.3.e005841.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"},{"key":"2026090206000748000_14.3.e005841.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.03.006"},{"key":"2026090206000748000_14.3.e005841.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00448-y"},{"key":"2026090206000748000_14.3.e005841.8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature New Biol"},{"key":"2026090206000748000_14.3.e005841.9","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061774","article-title":"Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review","volume":"13","author":"Sasc\u0103u","year":"2021","journal-title":"Nutrients"},{"key":"2026090206000748000_14.3.e005841.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027966"},{"key":"2026090206000748000_14.3.e005841.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01554-0","article-title":"The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus","volume":"21","author":"Hu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026090206000748000_14.3.e005841.12","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa252"},{"key":"2026090206000748000_14.3.e005841.13","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/eurheartj\/ehz778","article-title":"Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics","volume":"41","author":"Boden","year":"2020","journal-title":"Eur Heart J"},{"key":"2026090206000748000_14.3.e005841.14","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/j.jacl.2024.03.006","article-title":"Remnant cholesterol is associated with the progression and regression of metabolic dysfunction-associated steatotic liver disease in Chinese adults","volume":"18","author":"Guo","year":"2024","journal-title":"J Clin Lipidol"},{"key":"2026090206000748000_14.3.e005841.15","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1210\/clinem\/dgad272","article-title":"Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease","volume":"108","author":"Huang","year":"2023","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"2026090206000748000_14.3.e005841.16","doi-asserted-by":"crossref","unstructured":"Sun Y , Miao X , Hu M , et al . Remnant cholesterol and its variability independent of low density lipoprotein cholesterol predict metabolic dysfunction associated steatotic liver disease. Sci Rep 2025;15. doi:10.1038\/s41598-025-88000-9","DOI":"10.1038\/s41598-025-88000-9"},{"key":"2026090206000748000_14.3.e005841.17","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M700505-JLR200"},{"key":"2026090206000748000_14.3.e005841.18","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-023-06016-0","article-title":"Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study","volume":"66","author":"Wadstr\u00f6m","year":"2023","journal-title":"Diabetologia"},{"key":"2026090206000748000_14.3.e005841.19","doi-asserted-by":"crossref","first-page":"123211","DOI":"10.1016\/j.lfs.2024.123211","article-title":"Metabolic disorders, inter-organ crosstalk, and inflammation in the progression of metabolic dysfunction-associated steatotic liver disease","volume":"359","author":"Wang","year":"2024","journal-title":"Life Sci (1962)"},{"key":"2026090206000748000_14.3.e005841.20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.hest.2025.10.003","article-title":"Tongji Biobank: A High-Quality Repository Integrating Multi-Dimensional Biomedical Data","volume":"6","author":"Sun","year":"2025","journal-title":"Brain Hemorrhages"},{"key":"2026090206000748000_14.3.e005841.21","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1179733","article-title":"Cigarette smoking and risk of suicide in bipolar disorder: a systematic review","volume":"14","author":"Garc\u00eda-Jim\u00e9nez","year":"2023","journal-title":"Front Psychiatry"},{"key":"2026090206000748000_14.3.e005841.22","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2026090206000748000_14.3.e005841.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"2026090206000748000_14.3.e005841.24","unstructured":"Diagnosis and classification of diabetes: standards of care in diabetes\u20142025[EB]. 2025."},{"key":"2026090206000748000_14.3.e005841.25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"2026090206000748000_14.3.e005841.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab432"},{"key":"2026090206000748000_14.3.e005841.27","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4158\/CS-2020-0490","article-title":"Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr Pract"},{"key":"2026090206000748000_14.3.e005841.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-023-02733-w","article-title":"Longitudinal association of remnant cholesterol with joint arteriosclerosis and atherosclerosis progression beyond LDL cholesterol","volume":"21","author":"Wu","year":"2023","journal-title":"BMC Med"},{"key":"2026090206000748000_14.3.e005841.29","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.124.321165"},{"key":"2026090206000748000_14.3.e005841.30","doi-asserted-by":"publisher","DOI":"10.1177\/2047487315569411"},{"key":"2026090206000748000_14.3.e005841.31","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.264515"},{"key":"2026090206000748000_14.3.e005841.32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jare.2024.12.015","article-title":"Predictive value of remnant cholesterol inflammatory index for stroke risk: Evidence from the China health and Retirement Longitudinal study","volume":"76","author":"Chen","year":"2025","journal-title":"J Adv Res"},{"key":"2026090206000748000_14.3.e005841.33","doi-asserted-by":"crossref","first-page":"e2064","DOI":"10.1210\/clinem\/dgae597","article-title":"Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology","volume":"110","author":"Miyake","year":"2025","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"2026090206000748000_14.3.e005841.34","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/STROKEAHA.124.046811","article-title":"Discordant High Remnant Cholesterol With LDL-C Increases the Risk of Stroke: A Chinese Prospective Cohort Study","volume":"55","author":"Han","year":"2024","journal-title":"Stroke"},{"key":"2026090206000748000_14.3.e005841.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00262-5"},{"key":"2026090206000748000_14.3.e005841.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.008"},{"key":"2026090206000748000_14.3.e005841.37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6613827","article-title":"NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2","volume":"2021","author":"Maru\u0161i\u0107","year":"2021","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"key":"2026090206000748000_14.3.e005841.38","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"2026090206000748000_14.3.e005841.39","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","article-title":"Hepatic steatosis, low-grade chronic inflammation and hormone\/growth factor\/adipokine imbalance","volume":"16","author":"Tarantino","year":"2010","journal-title":"World J Gastroenterol"},{"key":"2026090206000748000_14.3.e005841.40","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"key":"2026090206000748000_14.3.e005841.41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacl.2021.01.005","article-title":"JCL roundtable: Lipids and inflammation in atherosclerosis","volume":"15","author":"Bornfeldt","year":"2021","journal-title":"J Clin Lipidol"},{"key":"2026090206000748000_14.3.e005841.42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003008"},{"key":"2026090206000748000_14.3.e005841.43","doi-asserted-by":"crossref","unstructured":"Kraaijenhof JM , Kerkvliet MJ , Nurmohamed NS , et al . Systemic Inflammation Is a Minor Contributor to Remnant Cholesterol Atherogenicity. Cold Spring Harbor Laboratory, 2024.","DOI":"10.1101\/2024.07.18.604203"},{"key":"2026090206000748000_14.3.e005841.44","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab705"},{"key":"2026090206000748000_14.3.e005841.45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab293"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2025-005841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:00:17Z","timestamp":1788354017000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2025-005841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,16]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjdrc-2025-005841"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2025-005841","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}